NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma

Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407

Abstract

Metadata

Authors/Creators:
  • Mukherjee, S
  • Hurt, CN
  • Gwynne, S
  • Bateman, A
  • Gollins, S
  • Radhakrishna, G
  • Hawkins, M
  • Canham, J
  • Lewis, W
  • Grabsch, HI
  • Sharma, RA
  • Wade, W
  • Maggs, R
  • Tranter, B
  • Roberts, A
  • Sebag-Montefiore, D
  • Maughan, T
  • Griffiths, G
  • Crosby, T
Copyright, Publisher and Additional Information: © 2015 Mukherjee et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Keywords: Oesophageal; Phase II; Neo-adjuvant; Chemotherapy; Chemoradiotherapy; Radiotherapy; Carboplatin; Paclitaxel; Oxaliplatin; Capecitabine
Dates:
  • Accepted: 30 January 2015
  • Published: 12 February 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Oncology and Clinical Research (Leeds) > Oncolocy/Cancer Research UK Clinical Centre (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Oct 2015 13:12
Last Modified: 12 Feb 2019 14:16
Published Version: http://dx.doi.org/10.1186/s12885-015-1062-y
Status: Published
Publisher: Biomed Central
Identification Number: https://doi.org/10.1186/s12885-015-1062-y
Related URLs:

Export

Statistics